Results 51 to 60 of about 921,945 (165)
Identifying Promising Immunomodulators for Type 1 Diabetes (T1D) and Islet Transplantation
Journal of Diabetes Research, Volume 2024, Issue 1, 2024.Type 1 diabetes (T1D) is an autoimmune chronic disorder that damages beta cells in the pancreatic islets of Langerhans and results in hyperglycemia due to the loss of insulin. Exogenous insulin therapy can save lives but does not stop disease progression.
Nida Ajmal +6 more
wiley +1 more source
Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei. [PDF]
, 2014 Closely related African trypanosomes cause lethal diseases but display distinct host ranges. Specifically, Trypanosoma brucei brucei causes nagana in livestock but fails to infect humans, while Trypanosoma brucei gambiense and Trypanosoma brucei ...
Currier, Rachel B. +18 more
core +1 more source
, 1961 Letter from Swiss Serum and Vaccine Institute Berne to Sabin, Albert B.
Swiss Serum and Vaccine Institute Berne
core +1 more source
Percutaneous Nephrostomy for Treatment of Posttransplant Ureteral Obstructions
Urology Journal, 2008 Introduction: We report our experience with percutaneous management of urologic complications following kidney transplantation.Materials and Methods: Of 1402 consecutive kidney transplant recipients from living donors at our hospital, 21 required ...
Mohammad Hossein Nourbala +3 more
doaj
Preoperative Serum Placenta Growth Factor Level Is a Prognostic Biomarker in Colorectal Cancer
, 2011 PURPOSE: Increased angiogenesis at the site of the primary tumor in colorectal cancer has been associated with poor prognosis and relapse of disease. We previously demonstrated that the tissue level of placenta growth factor expression was upregulated in
WEI, SHU-CHEN;LIANG, JIN-TUNG;TSAO, PO-NIEN;HSIEH, FON-JOU;YU, SENG-CHANG;WONG, JAU-MIN +1 more
core +1 more source
A low percentage of autologous serum can replace bovine serum to engineer human nasal cartilage [PDF]
, 2008 For the generation of cell-based therapeutic products, it would be preferable to avoid the use of animal-derived components. Our study thus aimed at investigating the possibility to replace foetal bovine serum (FBS) with autologous serum (AS) for the ...
Farhadi, J. +11 more
core +1 more source
Antilymphocyte Serum In Nephrotoxic Serum Nephritis
Experimental Biology and Medicine, 1970 SummaryALS administration failed to influence the clinical, biochemical, morphological including ultrastructural and immuno-histochemical features of the so-called homolous, and autologous phases of nephrotoxic serum nephritis in rats. This indicates that progression of this form of experimental renal disease is not necessarily dependent upon ...
E R, Fisher, B, Fisher
openaire +2 more sources
Cold reactive antilymphocyte antibodies in neurological diseases
, 1979 S U M MARY Cold reactive (150C) antilymphocyte antibodies were detected in the sera of 33 % of patients with multiple sclerosis, 50 % with Guillain-Barre syndrome, 42 % with myas-thenia gravis, and 38 % with polymyositis.
Burton Zweiman +2 more
core
, 2005 Cytomegalovirus (CMV) infection is highly prevalent in transplant patients, especially in those submitted to a more intense immunosuppression. We monitored CMV infection in 34 patients during 60 days after antilymphocyte therapy without CMV prophylaxis ...
Camara, NOS +4 more
core +1 more source
Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma [PDF]
, 2011 Background: MicroRNA-21 (miR-21) is up-regulated in tumor tissue of patients with malignant diseases, including hepatocellular carcinoma (HCC). Elevated concentrations of miR-21 have also been found in sera or plasma from patients with malignancies ...
Polta, Andreas +55 more
core +2 more sources